Autopsy report · NCT05453357

Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women

“Funding ended before enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

University of Arkansas

Sponsor type

University, hospital or other

Conditions

Diabetes, Gestational; Diabetes Mellitus Type 2 Pre-Existing

Interventions

iGlucose

Participants

0

Trials that died the same way

• Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
  “Funding has ended prior to complete enrollment” (96% match in meaning)
• Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia
  “Loss of funding before enrollment.” (83% match in meaning)
• BREATHE-Easy Trial
  “Funding completion date passed, inadequate enrollment” (82% match in meaning)
• Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
  “Funding ended prematurely” (81% match in meaning)
• Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation
  “low enrollment, termination of funding” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.